Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines

Molecular Carcinogenesis

Volumn 16, Issue 4, 1996, Pages 221-228

  Terry, Lori A ^a,d   Boyd, Jeff ^a   Alcorta, David ^a   Lyon, Tracy ^a   Solomon, Greg ^a   Hannon, Greg ^b   Berchuck, Andrew ^c   Beach, David ^b   Barrett, J Carl ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c DUKE UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cell cycle regulation; Cyclin dependent kinase inhibitor; p21; Polymorphism; Single strand conformational analysis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR;

AMINO ACID SUBSTITUTION; ARTICLE; CELL CYCLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; POLYMORPHISM, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029745148     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199608)16:4<221::AID-MC6>3.0.CO;2-I     Document Type: Article

References (46)

1. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704, 1993.
2. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993.
3. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816, 1993.
4. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90-98, 1994.
5. Zhang H, Xiong Y, Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4:897-906, 1993.
6. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578, 1994.
7. Li R, Waga S, Hannon GJ, Beach D, Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371:534-537, 1994.
8. Flores-Rozas H, Kelman Z, Dean FB, et al. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase 8 holoenzyme. Proc Natl Acad Sci USA 91:8655-8659, 1994.
9. Cip1. Nature 375:159-161, 1995.
10. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396, 1994.
11. Cip1 in muscle and other terminally differentiating cells. Science 267:1024-1027, 1995.
12. Halevy O, Novitch BG, Spicer DB, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021, 1995.
13. Jiang H, Lin J, Su Z, Collart FR, Huberman E, Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397-3406, 1994.
14. Macleod KF, Sherry N, Hannon G, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9:935-944, 1995.
15. Namba H, Hara T, Tukazaki T, et al. Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells. Cancer Res 55:2075-2080, 1995.
16. El-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/OP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174, 1994.
17. Di Leonardo A, Linke SP, Clarkin K, Wahl GM. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8:2540-2551, 1994.
18. Bae I, Smith ML, Fornace AJ, Jr. Induction of p53-, MDM2-, and WAF1/CIP1 like molecules in insect cells by DNA-damaging agents. Exp Cell Res 217:541-545, 1995.
19. Dulic V, Kaufmann WK, Wilson SJ, et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023, 1994.
20. Johnson M, Dimitrov D, Vojta PJ, et al. Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol Carcinog 11:59-64, 1994.
21. Sheikh WS, Li X-S, Chen J-C, Shao Z-M, Ordonez JV, Fontana JA. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: Role of p53-dependent and independent signal transduction pathways. Oncogene 9:3407-3416, 1994.
22. WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest 95:973-979, 1995.
23. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395, 1994.
24. Bhatia K, Fan S, Spangler G, et al. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma. Cancer Res 55:1431-1435, 1995.
25. Shiohara M, El-Deiry WS, Wada M, et al. Absence of WAF1 mutations in a variety of human malignancies. Blood 84:3781-3784, 1994.
26. Li Y-J, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene 10:599-601, 1995.
27. Marchetti A, Buttitta F, Pellegrini S, Bertacca G, Lori A, Bevilacqua G. Absence of somatic mutations in the coding region of the WAF1/CIP1 gene in human breast, lung, and ovarian carcinomas: A polymorphism at codon 31. International Journal of Oncology 6:187-189, 1995.
28. Cip1/Waf1 cyclin-dependent kinase inhibitor gene. Hum Genet 95:459-460, 1995.
29. ser-arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): The polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiol Biomarkers Prev 4:261-267, 1995.
30. Chedid M, Michieli P, Lengel C, Huppi K, Givol D. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/ CIP1. Oncogene 9:3021-3024, 1994.
31. Kamb A. Cell-cycle regulators and cancer. Trends Genet 11:136-140, 1995.
32. 1 by human endometrial carcinoma cell lines: Inverse correlation with effects on growth rate and morphology. Cancer Res 50:3394-3399, 1990.
33. Boyd JA, Rinehart CA, Walton LA, Siegal GP, Kaufman DG. Ultrastructural characterization of two new human endometrial carcinoma cell lines and normal human endometrial epithelial cells cultured on extracellular matrix. In Vitro Cell Dev Biol 26:701-708, 1990.
34. Boyd JA, Siegal GP, Kaufman DG. Establishment and characterization of a human cell line from a serous papillary endometrial carcinoma. Gynecol Oncol 33:301-312, 1989.
35. Holinka CF, Hata H, Kuramoto H, Gurpide E. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line). Cancer Res 46:2771-2774, 1986.
36. Morisawa T. The results of primary culture of endometrial adenocarcinoma and characterization of its established cell line. Journal of the Japanese Society of Clinical Cytology 26:433-442, 1987.
37. Fujino T, Risinger JI, Collins NK, et al. Allelotype of endometrial carcinoma. Cancer Res 54:4294-4298, 1994.
38. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
39. Stockschlaeder MAR, Storb R, Osborne WRA, Miller AD. L-histidinol provides effective selection of retrovirus-vector-infected keratinocytes without impairing their proliferative potential. Hum Gene Ther 2:33-39, 1991.
40. Wigler M, Pellicer A, Silverstein S, Axel R. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14:725-731, 1978.
41. Lester SC, LeVan SK, Steglich C, DeMars R. Expression of human genes for adenine phosphoribosyltransferase and hypoxanthineguanine phosphoribosyltransferase after genetic transformation of mouse cells with purified human DNA. Somatic Cell Genet 6:241-259, 1980,
42. Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915, 1990.
43. WAF1/CIP1expression in normal and neoplastic tissues. Cancer Res 55:2910-2919, 1995.
44. WAF1 and proliferating cell nuclear antigen. Curr Biol 5:275-282, 1995.
45. Canman CE, Gilmer TM, Coutts SB, Kastan MB. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 9:600-611, 1995.
46. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530, 1995.